Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 9861
  • 9862
  • 9863
  • …
  • ›
  • »

2026-04-01

IN BRIEF: AG Barr CEO Euan Sutherland buys shares after annual results

2026-04-01

CML Microsystem eyes return to profit despite slower momentum

2026-04-01

IN BRIEF: Lion Finance head of Mass Retail sells 1,000 shares

2026-04-01

IN BRIEF: IMI COO Jun Hu sells PS260,000 in shares

2026-04-01

InTest appoints Rich Rogoff as CEO

2026-04-01

NovaGold Resources GAAP EPS of -$0.04 misses by $0.01

2026-04-01

TuHURA Biosciences reports FY results

2026-04-01

VivoSim Announces Pricing of up to a $4 Million Public Offering

2026-04-01

Inseego Appoints Silvia Rocha-Espino as Head of People

2026-04-01

TDF Expands Broadcast Channel Lineup with Harmonic

2026-04-01

Shareholders in Wyld Networks proposes the acquisition of OKT Technology AB, a rights issue of shares and a by-election to the Board of Directors and Wyld Networks renegotiates previous loan

2026-04-01

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

  • «
  • ‹
  • …
  • 9861
  • 9862
  • 9863
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 03/Sep/2026 15:17:13
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies